Certain L-Tryptophan, L-Tryptophan Products, and Their Methods of Production: Notice of Request for Statements on the Public Interest, 39456-39457 [2017-17468]

Download as PDF 39456 Federal Register / Vol. 82, No. 159 / Friday, August 18, 2017 / Notices appearance in the preliminary phase of the investigation need not enter a separate appearance for the final phase of the investigation. Industrial users, and, if the merchandise under investigation is sold at the retail level, representative consumer organizations have the right to appear as parties in Commission antidumping and countervailing duty investigations. The Secretary will prepare a public service list containing the names and addresses of all persons, or their representatives, who are parties to the investigation. Background mstockstill on DSK30JT082PROD with NOTICES On June 28, 2017, The Timken Company, North Canton, Ohio, filed a petition with the Commission and Commerce, alleging that an industry in the United States is materially injured by reason of LTFV imports of tapered roller bearings from Korea. Accordingly, effective June 28, 2017, the Commission, pursuant to section 733(a) of the Act (19 U.S.C. 1673b(a)), instituted antidumping duty investigation No. 731–TA–1380 (Preliminary). Notice of the institution of the Commission’s investigation and of a public conference to be held in connection therewith was given by posting copies of the notice in the Office of the Secretary, U.S. International Trade Commission, Washington, DC, and by publishing the notice in the Federal Register of July 5, 2017 (82 FR 31067). The conference was held in Washington, DC, on July 19, 2017, and all persons who requested the opportunity were permitted to appear in person or by counsel. The Commission made this determination pursuant to section 733(a) of the Act (19 U.S.C. 1673b(a)). It completed and filed its determination in this investigation on August 14, 2017. The views of the Commission are contained in USITC Publication 4721 (August 2017), entitled Tapered Roller Bearings from Korea: Investigation No. 731–TA–1380 (Preliminary). By order of the Commission. Issued: August 14, 2017. William R. Bishop, Supervisory Hearings and Information Officer. [FR Doc. 2017–17467 Filed 8–17–17; 8:45 am] BILLING CODE 7020–02–P VerDate Sep<11>2014 17:47 Aug 17, 2017 Jkt 241001 Section 337 of the Tariff Act of 1930 provides that if the Commission finds a violation it shall exclude the articles concerned from the United States: INTERNATIONAL TRADE COMMISSION [Investigation No. 337–TA–1005] Certain L-Tryptophan, L-Tryptophan Products, and Their Methods of Production: Notice of Request for Statements on the Public Interest U.S. International Trade Commission. ACTION: Notice. AGENCY: Notice is hereby given that the presiding administrative law judge has issued a Final Initial Determination and Recommended Determination on Remedy and Bonding in the abovecaptioned investigation. This notice is soliciting public interest comments from the public only. Parties are to file public interest submissions pursuant to Commission rules. FOR FURTHER INFORMATION CONTACT: Houda Morad, Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436, telephone (202) 708–4716. The public version of the complaint can be accessed on the Commission’s electronic docket (EDIS) at https://edis.usitc.gov, and will be available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436, telephone (202) 205–2000. General information concerning the Commission may also be obtained by accessing its Internet server (https:// www.usitc.gov). The public record for this investigation may be viewed on the Commission’s electronic docket (EDIS) at https://edis.usitc.gov. Hearingimpaired persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on (202) 205–1810. SUPPLEMENTARY INFORMATION: The Commission is soliciting comments on public interest issues raised by the recommended relief, should the Commission find a violation, specifically: (1) A limited exclusion order (‘‘LEO’’) against certain Ltryptophan, L-tryptophan products, and their methods of production, which are imported, sold for importation, and/or sold after importation by Respondents CJ CheilJedang Corp. of Seoul, Republic of Korea, CJ America, Inc. (‘‘CJ America’’) of Downers Grove, Illinois, and PT CheilJedang Indonesia of Jakarta, Indonesia (collectively ‘‘CJ’’ or ‘‘Respondents’’); and (2) a cease and desist order (‘‘CDO’’) against Respondent CJ America. SUMMARY: PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 unless, after considering the effect of such exclusion upon the public health and welfare, competitive conditions in the United States economy, the production of like or directly competitive articles in the United States, and United States consumers, it finds that such articles should not be excluded from entry. 19 U.S.C. 1337(d)(1). A similar provision applies to cease and desist orders. 19 U.S.C. 1337(f)(1). The Commission is interested in further development of the record on the public interest in these investigations. Accordingly, parties are to file public interest submissions pursuant to pursuant to 19 CFR 210.50(a)(4). In addition, members of the public are hereby invited to file submissions of no more than five (5) pages, inclusive of attachments, concerning the public interest in light of the administrative law judge’s Recommended Determination on Remedy and Bonding issued in this investigation on August 11, 2017. Comments should address whether issuance of the LEO and CDO in this investigation, should the Commission find a violation, would affect the public health and welfare in the United States, competitive conditions in the United States economy, the production of like or directly competitive articles in the United States, or United States consumers. In particular, the Commission is interested in comments that: (i) Explain how the articles potentially subject to the recommended orders are used in the United States; (ii) identify any public health, safety, or welfare concerns in the United States relating to the recommended orders; (iii) identify like or directly competitive articles that complainants, their licensees, or third parties make in the United States which could replace the subject articles if they were to be excluded; (iv) indicate whether complainants, complainants’ licensees, and/or third party suppliers have the capacity to replace the volume of articles potentially subject to the recommended exclusion order and/or a cease and desist order within a commercially reasonable time; and (v) explain how the LEO and CDO would impact consumers in the United States. Written submissions from the public must be filed no later than by close of business on Wednesday, September 20, 2017. E:\FR\FM\18AUN1.SGM 18AUN1 Federal Register / Vol. 82, No. 159 / Friday, August 18, 2017 / Notices Persons filing written submissions must file the original document electronically on or before the deadlines stated above and submit 8 true paper copies to the Office of the Secretary by noon the next day pursuant to section 210.4(f) of the Commission’s Rules of Practice and Procedure (19 CFR 210.4(f)). Submissions should refer to the investigation number (‘‘Inv. No. 337–TA–1005’’) in a prominent place on the cover page and/or the first page. (See Handbook for Electronic Filing Procedures, https://www.usitc.gov/ secretary/fed_reg_notices/rules/ handbook_on_electronic_filing.pdf). Persons with questions regarding filing should contact the Secretary (202–205– 2000). Any person desiring to submit a document to the Commission in confidence must request confidential treatment. All such requests should be directed to the Secretary to the Commission and must include a full statement of the reasons why the Commission should grant such treatment. See 19 CFR 201.6. Documents for which confidential treatment by the Commission is properly sought will be treated accordingly. A redacted nonconfidential version of the document must also be filed simultaneously with any confidential filing. All nonconfidential written submissions will be available for public inspection at the Office of the Secretary and on EDIS. This action is taken under the authority of section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and of sections 201.10 and 210.50 of the Commission’s Rules of Practice and Procedure (19 CFR 201.10, 210.50). By order of the Commission. Issued: August 14, 2017. William R. Bishop, Supervisory Hearings and Information Officer. [FR Doc. 2017–17468 Filed 8–17–17; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE [OMB Number 1117–NEW] mstockstill on DSK30JT082PROD with NOTICES Agency Information Collection Activities; Proposed eCollection eComments Requested; DEA Ambassador Program Drug Enforcement Administration, Department of Justice. ACTION: 30-day Notice. AGENCY: The Department of Justice (DOJ), Drug Enforcement Administration, will be submitting the SUMMARY: VerDate Sep<11>2014 17:47 Aug 17, 2017 Jkt 241001 following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. This proposed information collection was previously published in the Federal Register at 82 FR 28355, on June 21, 2017, allowing for a 60-day comment period. DATES: Comments are encouraged and will be accepted for 30 days until September 18, 2017. FOR FURTHER INFORMATION CONTACT: If you have additional comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Gary R. Owen, Chief, Office of Congressional & Public Affairs, Drug Enforcement Administration, 8701 Morrissette Drive, Springfield, VA 22152. Written comments and/or suggestions can also be sent to the Office of Management and Budget, Office of Information and Regulatory Affairs, Attention: Department of Justice Desk Officer, Washington, DC 20503 or sent to OIRA_submissions@ omb.eop.gov. SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Evaluate whether and if so how the quality, utility, and clarity of the information to be collected can be enhanced; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection 1. Type of Information Collection: Proposed collection. PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 39457 2. The Title of the Form/Collection: DEA Ambassador Program (DAP) Volunteer Application. 3. The agency form number, if any, and the applicable component of the Department sponsoring the collection: The form number is DEA–320. The applicable component within the Department of Justice is the Drug Enforcement Administration. 4. Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Individuals. The Ambassador Program is designed to enhance the ability of the DEA Field Divisions to cultivate and leverage community relationships for the purpose of increasing illicit drug prevention and education strategies. 5. An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: It is estimated that 100 respondents will complete the application in approximately 10 minutes. 6. An estimate of the total public burden (in hours) associated with the collection: The estimated public burden associated with this collection is 16.6 hours. It is estimated that applicants will take 10 minutes to complete the DEA–320. The burden hours for collecting respondent data sum to 1,000 hours (100 respondents × 10 minutes = 1,000 hours). 1,000/60 seconds = 16.6. If additional information is required contact: Melody Braswell, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N street NE., 3E.405B, Washington, DC 20530. Dated: August 15, 2017. Melody Braswell, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2017–17469 Filed 8–17–17; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Notice of Lodging of Proposed Consent Decree Under the Clean Air Act On August 14, 2017, the Department of Justice lodged a proposed Consent Decree (‘‘Consent Decree’’) with the United States District Court for the District of Connecticut in the lawsuit entitled United States v. City of Waterbury, CT and Synagro Northeast, LLC, Civil Action No. 2:17–cv–01377. In a Complaint, the United States, on behalf of the U.S. Environmental Protection Agency (‘‘EPA’’), alleges that E:\FR\FM\18AUN1.SGM 18AUN1

Agencies

[Federal Register Volume 82, Number 159 (Friday, August 18, 2017)]
[Notices]
[Pages 39456-39457]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-17468]



-----------------------------------------------------------------------



INTERNATIONAL TRADE COMMISSION



[Investigation No. 337-TA-1005]




Certain L-Tryptophan, L-Tryptophan Products, and Their Methods of 

Production: Notice of Request for Statements on the Public Interest



AGENCY: U.S. International Trade Commission.



ACTION: Notice.



-----------------------------------------------------------------------



SUMMARY: Notice is hereby given that the presiding administrative law 

judge has issued a Final Initial Determination and Recommended 

Determination on Remedy and Bonding in the above-captioned 

investigation. This notice is soliciting public interest comments from 

the public only. Parties are to file public interest submissions 

pursuant to Commission rules.



FOR FURTHER INFORMATION CONTACT: Houda Morad, Office of the General 

Counsel, U.S. International Trade Commission, 500 E Street SW., 

Washington, DC 20436, telephone (202) 708-4716. The public version of 

the complaint can be accessed on the Commission's electronic docket 

(EDIS) at https://edis.usitc.gov, and will be available for inspection 

during official business hours (8:45 a.m. to 5:15 p.m.) in the Office 

of the Secretary, U.S. International Trade Commission, 500 E Street 

SW., Washington, DC 20436, telephone (202) 205-2000.

    General information concerning the Commission may also be obtained 

by accessing its Internet server (https://www.usitc.gov). The public 

record for this investigation may be viewed on the Commission's 

electronic docket (EDIS) at https://edis.usitc.gov. Hearing-impaired 

persons are advised that information on this matter can be obtained by 

contacting the Commission's TDD terminal on (202) 205-1810.



SUPPLEMENTARY INFORMATION: The Commission is soliciting comments on 

public interest issues raised by the recommended relief, should the 

Commission find a violation, specifically: (1) A limited exclusion 

order (``LEO'') against certain L-tryptophan, L-tryptophan products, 

and their methods of production, which are imported, sold for 

importation, and/or sold after importation by Respondents CJ 

CheilJedang Corp. of Seoul, Republic of Korea, CJ America, Inc. (``CJ 

America'') of Downers Grove, Illinois, and PT CheilJedang Indonesia of 

Jakarta, Indonesia (collectively ``CJ'' or ``Respondents''); and (2) a 

cease and desist order (``CDO'') against Respondent CJ America.

    Section 337 of the Tariff Act of 1930 provides that if the 

Commission finds a violation it shall exclude the articles concerned 

from the United States:



unless, after considering the effect of such exclusion upon the 

public health and welfare, competitive conditions in the United 

States economy, the production of like or directly competitive 

articles in the United States, and United States consumers, it finds 

that such articles should not be excluded from entry.



19 U.S.C. 1337(d)(1). A similar provision applies to cease and desist 

orders. 19 U.S.C. 1337(f)(1).

    The Commission is interested in further development of the record 

on the public interest in these investigations. Accordingly, parties 

are to file public interest submissions pursuant to pursuant to 19 CFR 

210.50(a)(4). In addition, members of the public are hereby invited to 

file submissions of no more than five (5) pages, inclusive of 

attachments, concerning the public interest in light of the 

administrative law judge's Recommended Determination on Remedy and 

Bonding issued in this investigation on August 11, 2017. Comments 

should address whether issuance of the LEO and CDO in this 

investigation, should the Commission find a violation, would affect the 

public health and welfare in the United States, competitive conditions 

in the United States economy, the production of like or directly 

competitive articles in the United States, or United States consumers.

    In particular, the Commission is interested in comments that:

    (i) Explain how the articles potentially subject to the recommended 

orders are used in the United States;

    (ii) identify any public health, safety, or welfare concerns in the 

United States relating to the recommended orders;

    (iii) identify like or directly competitive articles that 

complainants, their licensees, or third parties make in the United 

States which could replace the subject articles if they were to be 

excluded;

    (iv) indicate whether complainants, complainants' licensees, and/or 

third party suppliers have the capacity to replace the volume of 

articles potentially subject to the recommended exclusion order and/or 

a cease and desist order within a commercially reasonable time; and

    (v) explain how the LEO and CDO would impact consumers in the 

United States.

    Written submissions from the public must be filed no later than by 

close of business on Wednesday, September 20, 2017.



[[Page 39457]]



    Persons filing written submissions must file the original document 

electronically on or before the deadlines stated above and submit 8 

true paper copies to the Office of the Secretary by noon the next day 

pursuant to section 210.4(f) of the Commission's Rules of Practice and 

Procedure (19 CFR 210.4(f)). Submissions should refer to the 

investigation number (``Inv. No. 337-TA-1005'') in a prominent place on 

the cover page and/or the first page. (See Handbook for Electronic 

Filing Procedures, https://www.usitc.gov/secretary/fed_reg_notices/rules/handbook_on_electronic_filing.pdf). Persons with questions 

regarding filing should contact the Secretary (202-205-2000).

    Any person desiring to submit a document to the Commission in 

confidence must request confidential treatment. All such requests 

should be directed to the Secretary to the Commission and must include 

a full statement of the reasons why the Commission should grant such 

treatment. See 19 CFR 201.6. Documents for which confidential treatment 

by the Commission is properly sought will be treated accordingly. A 

redacted non-confidential version of the document must also be filed 

simultaneously with any confidential filing. All non-confidential 

written submissions will be available for public inspection at the 

Office of the Secretary and on EDIS.

    This action is taken under the authority of section 337 of the 

Tariff Act of 1930, as amended (19 U.S.C. 1337), and of sections 201.10 

and 210.50 of the Commission's Rules of Practice and Procedure (19 CFR 

201.10, 210.50).



    By order of the Commission.



    Issued: August 14, 2017.

William R. Bishop,

Supervisory Hearings and Information Officer.

[FR Doc. 2017-17468 Filed 8-17-17; 8:45 am]

BILLING CODE 7020-02-P